SCHEMBL4265186

SCHEMBL4265186

CCCCCCNC(=S)Nc1ccc2c(c1)Cc1cc(Br)ccc1-2

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 2/20 0.51
CYP2C9 P11712 1/20 0.51
CYP2C19 P33261 1/20 0.51
RAB9A P51151 3/20 0.47
NPC1 O15118 2/20 0.47
CYP3A4 P08684 1/20 0.47
SMN1; SMN2 Q16637 4/20 0.46
LMNA P02545 4/20 0.46
HTT P42858 3/20 0.46
KMT2A Q03164 2/20 0.46
MEN1 O00255 1/20 0.46
GSK3B P49841 3/20 0.45
HDAC1 Q13547 3/20 0.45
HDAC6 Q9UBN7 3/20 0.45
SLC1A3 P43003 1/20 0.45
SLC1A2 P43004 1/20 0.45
SLC1A1 P43005 1/20 0.45
GAA P10253 2/20 0.44
HPGD P15428 1/20 0.44
RECQL P46063 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3980293 1.00 CYP1A2 (0.51) CYP1A2CYP2C9CYP2C19RAB9ANPC1
SCHEMBL3977111 1.00 CYP1A2 (0.51) CYP1A2CYP2C9CYP2C19RAB9ANPC1
SCHEMBL3982022 0.99 CYP1A2 (0.52) CYP1A2CYP2C9CYP2C19RAB9ANPC1
SCHEMBL4261173 0.95 CYP1A2 (0.53) CYP1A2CYP2C9CYP2C19RAB9ANPC1
SCHEMBL3981627 0.90 CYP1A2 (0.63) CYP1A2CYP2C9CYP2C19RAB9ANPC1
SCHEMBL3977078 0.85 CYP1A2 (0.54) CYP1A2CYP2C9CYP2C19RAB9ANPC1
SCHEMBL3977663 0.85 GAA (0.53) CYP1A2CYP2C9CYP2C19RAB9ANPC1
SCHEMBL3983507 0.85 ALDH1A1 (0.52) CYP1A2CYP2C9CYP2C19RAB9ANPC1
SCHEMBL3983505 0.83 MAPT (0.56) CYP1A2CYP2C9CYP2C19RAB9ANPC1
SCHEMBL3984516 0.83 RAB9A (0.58) CYP1A2CYP2C9CYP2C19RAB9ANPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101522184-A Thiourea compounds NAT HEALTH RESEARCH INSTITUTES (CN) 2009-09-02 CN disclosed
EP-2056810-A2 THIOUREA COMPOUNDS National Health Research Institutes (TW) 2009-05-13 EP disclosed
US-20080113975-A1 THIOUREA COMPOUNDS NATIONAL HEALTH RESEARCH INSTITUTES (TW) 2008-05-15 US disclosed
US-20080113975-A1 THIOUREA COMPOUNDS NATIONAL HEALTH RESEARCH INSTITUTES (TW) 2008-05-15 US disclosed
US-20080113975-A1 THIOUREA COMPOUNDS NATIONAL HEALTH RESEARCH INSTITUTES (TW) 2008-05-15 US disclosed
US-20080096875-A1 THIOUREA COMPOUNDS NATIONAL HEALTH RESEARCH INSTITUTES (TW) 2008-04-24 US disclosed
US-20080096875-A1 THIOUREA COMPOUNDS NATIONAL HEALTH RESEARCH INSTITUTES (TW) 2008-04-24 US disclosed
US-20080096875-A1 THIOUREA COMPOUNDS NATIONAL HEALTH RESEARCH INSTITUTES (TW) 2008-04-24 US disclosed
WO-2008022204-A2 THIOUREA COMPOUNDS NATIONAL HEALTH RESEARCH INSTITUTES (TW) 2008-02-21 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080096875-A1 THIOUREA COMPOUNDS TPMT, HAVCR2, ETV6 CYP1A2 555/4885CYP2C9 456/4885CYP2C19 1098/4885
US-20080113975-A1 THIOUREA COMPOUNDS TPMT, HAVCR2, EIF2AK2 CYP1A2 556/4885CYP2C9 459/4885CYP2C19 1115/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.